CN105193850A - Eye drop prepared from both traditional Chinese medicines and western medicines - Google Patents
Eye drop prepared from both traditional Chinese medicines and western medicines Download PDFInfo
- Publication number
- CN105193850A CN105193850A CN201410294130.0A CN201410294130A CN105193850A CN 105193850 A CN105193850 A CN 105193850A CN 201410294130 A CN201410294130 A CN 201410294130A CN 105193850 A CN105193850 A CN 105193850A
- Authority
- CN
- China
- Prior art keywords
- medicines
- traditional chinese
- eye drop
- western
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses an eye drop prepared from both traditional Chinese medicines and western medicines, and relates to technical field of agents for relieving eyestrain. The eye drop is characterized by comprising the constituents of liquid pearl, borneol, vitamin B6, taurine, aspartate, chloromycetin, naphazoline hydrochloride and dipotassium glycyrrhizinate. The eye drop integrates the characteristics of the traditional Chinese medicines and the western medicines, combines both the traditional Chinese medicines and the western medicines, and has the characteristics of being quick in effect and little in side effect.
Description
Technical field:
The present invention relates to and alleviate eyestrain's pharmaceutical techniques field, be specifically related to a kind of collyrium of Chinese medicine and western medicine set.
Background technology:
The oculopathy such as inflamed eyes, hyperemia, trachoma, keratitis annoying us always.At present, the collyrium on market is of a great variety.But, existing collyrium also exist therapeutic effect not good, mostly be pure Chinese medicine or pure Western medicine, slow, the pure Western medicine side effect that takes effect of pure Chinese medicine is larger.
Summary of the invention:
The object of this invention is to provide a kind of collyrium of Chinese medicine and western medicine set, it has gathered the feature of Chinese medicine and western medicine, adopts Chinese medicine and western medicine set to use, has instant effect, the feature that side effect is little.
In order to solve the problem existing for background technology, the present invention by the following technical solutions: its constituent has: Margarita liquid 80%-90%, Borneolum Syntheticum 2%-4%, vitamin B6 1-3%, taurine 1-2%, Aspartic Acid 0.1-1.0%, chloromycetin 0.1-0.5%, hydrochloric acid how first azoles woods 0.1-10.5%, glycyrrhizic acid dipotassium 0.1-0.5%.
The present invention has following beneficial effect: it has gathered the feature of Chinese medicine and western medicine, adopts Chinese medicine and western medicine set to use, has instant effect, the feature that side effect is little.
Detailed description of the invention:
This detailed description of the invention is by the following technical solutions: its constituent has: Margarita liquid 85%, Borneolum Syntheticum 3%, vitamin B6 2.4%, taurine 1.2%, Aspartic Acid 0.5%, chloromycetin 0.2%, hydrochloric acid is first azoles woods 0.3%, glycyrrhizic acid dipotassium 0.4% how.
Margarita has improving eyesight removing nebula and increases the effect looked; Borneolum Syntheticum has that heat clearing away is sensible, the effect of reducing swelling and alleviating pain; Vitamin B6 external can improve local nerve function and the reaction that reduces inflammation.Taurine is a kind of special aminoacid, is the requisite a kind of nutrient of human body, has effect of maintaining healthy.Scientific research finds that taurine has protective effect to eyes, lung, liver, gastrointestinal etc.In addition, taurine can also improve body immunity, maintains cardiac function, makes blood circulation normalization, thus allaying tiredness.Aspartic Acid has protective effect to liver and muscle; Naphcon can directly stimulate the receptor on blood vessel and cause vasoconstriction, thus reduce inflammation caused hyperemia and edema; Glycyrrhizic acid dipotassium can stop the release of histamine, has the effect such as antiinflammatory, antiallergic, moisturizing.
This detailed description of the invention has following beneficial effect: it has gathered the feature of Chinese medicine and western medicine, adopts Chinese medicine and western medicine set to use, has instant effect, the feature that side effect is little.
Claims (1)
1. a collyrium for Chinese medicine and western medicine set, is characterized in that its constituent has: Margarita liquid 80%-90%, Borneolum Syntheticum 2%-4%, vitamin B6 1-3%, taurine 1-2%, Aspartic Acid 0.1-1.0%, chloromycetin 0.1-0.5%, hydrochloric acid how first azoles woods 0.1-10.5%, glycyrrhizic acid dipotassium 0.1-0.5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410294130.0A CN105193850A (en) | 2014-06-24 | 2014-06-24 | Eye drop prepared from both traditional Chinese medicines and western medicines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410294130.0A CN105193850A (en) | 2014-06-24 | 2014-06-24 | Eye drop prepared from both traditional Chinese medicines and western medicines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105193850A true CN105193850A (en) | 2015-12-30 |
Family
ID=54942040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410294130.0A Pending CN105193850A (en) | 2014-06-24 | 2014-06-24 | Eye drop prepared from both traditional Chinese medicines and western medicines |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105193850A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109499A (en) * | 2016-06-29 | 2016-11-16 | 大连深蓝肽科技研发有限公司 | A kind of Apostichopus enzymolysis liquid collyrium and preparation method |
| CN111195265A (en) * | 2018-11-16 | 2020-05-26 | 周瑜帅 | Cleaning type eye drop capable of preventing dryness |
-
2014
- 2014-06-24 CN CN201410294130.0A patent/CN105193850A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109499A (en) * | 2016-06-29 | 2016-11-16 | 大连深蓝肽科技研发有限公司 | A kind of Apostichopus enzymolysis liquid collyrium and preparation method |
| CN111195265A (en) * | 2018-11-16 | 2020-05-26 | 周瑜帅 | Cleaning type eye drop capable of preventing dryness |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011146777A3 (en) | Device and method for providing a synergistic combination of phototherapy and a non-light energy modality to the brain | |
| WO2015049688A3 (en) | Patient-specific immunotherapy for treating heterogeneous tumors | |
| RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
| CN105193850A (en) | Eye drop prepared from both traditional Chinese medicines and western medicines | |
| CN102920976B (en) | External traditional Chinese medicine composition for preventing and treating liver cancer pain | |
| CN103933206B (en) | A kind of medicament lotion for treating old people's skin pruritus | |
| CN102283925A (en) | Traditional Chinese medicine for treating neurodynia resulted from herpes zoster | |
| CN108014294A (en) | A kind of Chinese medicine preparation for treating ovarian neoplasm | |
| CN209048419U (en) | One kind, which has to relieve pain, promotes local blood circulation cold compress drug paste | |
| WO2008079818A3 (en) | Intravenous administration of water soluble analgesic formulations | |
| CN103585231B (en) | A kind of medicine that alleviates geroderma itch | |
| CN105456472A (en) | Medicine for treating rheumatic arthritis | |
| WO2023049534A3 (en) | Subcutaneously administered foslevodopa/foscarbidopa treatments for advanced parkinson's disease | |
| CN104138425A (en) | Traditional Chinese medicine for treating postprandial hypoglycemia | |
| CN104147056B (en) | Composition containing bromhexine hydrochloride | |
| CN203988655U (en) | A kind of health care umbilicus medicated plaster | |
| CN104147007A (en) | Pharmaceutical composition for relieving pain and application thereof | |
| CN103446455A (en) | Traditional Chinese medicine for treating headache | |
| CN1569074A (en) | Medicine for treating scapulohumeral periarthritis | |
| CN105687893A (en) | Drug for treatment of hypertension | |
| CN106692932A (en) | Oral liquid | |
| CN105535744A (en) | Traditional Chinese medicine for treating angina pectoris and preparation method thereof | |
| CN106110231A (en) | A kind of Chinese medicine formula treating diabetic neuropathy | |
| CN109106769A (en) | A kind of drug for treating neurasthenia and insomnia | |
| Moon et al. | Scrambler Therapy: A Novel Approach to Pain Control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: He Jianjun Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: He Jianjun Document name: Notification that Application Deemed to be Withdrawn |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151230 |